Clinical Trial Update: Tislelizumab Combined with SOX and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Metastasis: a Prospective Cohort Study

View source ↗

Summary

A prospective cohort study evaluating tislelizumab in combination with SOX chemotherapy and HIPEC for gastric cancer with peritoneal metastasis; recruitment has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Gastric Cancer with Peritoneal Metastasis | Status: NOT_YET_RECRUITING